US 7442718
Inhibitors of aspartyl protease
granted A61PA61P31/18
Quick answer
US patent 7442718 (Inhibitors of aspartyl protease) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 23 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Oct 28 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 23 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P31/18